Germline testing results were available in only four patients and detected a pathogenic alteration in SMARCB1 in one patient with unclassified RCC and negative family history of cancer, and a variant of unknown significance in one patient with clear cell RCC (ccRCC). Here, SMARCB1 is linked to nonpapillary renal cell carcinoma.